unknown
Stage
About
Clade Therapeutics develops mid-infrared FTIR spectrometry-based bioanalytics technology for biopharma, enabling multi-attribute high-throughput analysis of biologics formulation components in aqueous solutions.
Explore Clade Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.